/Investor DB

Berggruen Holdings — 2017 Investments

2 investments dated 2017 · listed companies and verified rows first · show all

LabGeniuslabgeni.usin𝕏Oct 2017

LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.

AI & Machine LearningBiotechDeep TechLondon

Harrison Rickerby(Executive Officer, Director)

BoardJames Field(Founder)in

Co-investorsAcequia Capital (AceCap)Air Street CapitalAtomicoBackedBeast VenturesChampion Hill Ventures+10 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Mirror Emoji Keyboard

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.